Character Biosciences

About:

Biopharmaceutical research and development company

Website: https://characterbio.com

Top Investors: Cantos, Industry Ventures, Catalio Capital Management, Casdin Capital, Section 32

Description:

Character Therapeutics is a patient-driven therapeutics company that uses genomics, longitudinal clinical and imaging data, machine learning, and novel experimental approaches to identify the molecular drivers of disease progression and develop innovative targeted medicines. Its dedication to patients is reflected in the high standards set to ensure privacy, data security, ethics, scientific rigor, and a meaningful impact on patient health. To enable clinical genomic research, the company collaborates with patients, providers, payers, and scientists to create deeply phenotyped patient cohorts.

Total Funding Amount:

$27M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Jersey City, New Jersey, United States

Founded Date:

2018-01-01

Founders:

Cheng Zhang, Marcel van der Brug

Number of Employees:

11-50

Last Funding Date:

2022-09-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai